University of Liege
Also known as: Centre du Cerveau, Coma Science Group (GIGA Consciousness) | Centre Hospitalier Universitaire de Liege | Centre Hospitalier Universitaire de Liège | Centre Hospitalier Universitaire de Liège, Avenue de L'Hòpital , Belgium | CHU de Liège | CHU Liege | CHU Liège | CHU Liege (Belgium) | CHU Liege - Department of Anesthesia and Intensive Care Medicine | CHU Liege - Domaine Universitaire du Sart Tilman | CHU of Liège | CHU-ULG | Citadelle Hospital of Liege | Clinical Pharmacology Unit, Liege, Belgium | Dr. Stéphanie Delstanche | Jean François Brichant | J P Lecoq | Liege University Hospital | PARZIBUT Gilles | ULiège | Université de Liège | University Hospital of Liege | University Hospital of Liège | University of Liege | University of Liège | University of Liege, Belgium | University of Liege - Bone and Cartilage Research Unit | University of Liege, University Hospital | Vander Haegen Marie
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2003Last known activity
Mar 15, 2024
Timeline
1810s
- Jun 1, 1817
University of Liege— Founded
Drugs by trial phase (75 distinct, 71 trials)
Phase 4 (31 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Autoimmune Diseases
- Brain Injuries
- Carcinoma, Hepatocellular
- Communicable Diseases
- Consciousness Disorders
- Coronavirus Infections
- Crohn Disease
- Diabetes Mellitus, Type 2
- Disease
- Dyssomnias
- Exsanguination
- Fatigue
- Femur Head Necrosis
- Graft vs Host Disease
- Hemorrhage
- HIV Infections
- Hodgkin Disease
- Infections
- Joint Diseases
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Failure
- Liver Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Migraine Disorders
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Necrosis
- Neoplasms
- Osteoarthritis
- Osteoarthritis, Knee
- Osteonecrosis
- Parasomnias
- Persistent Vegetative State
- Postoperative Complications
- Postoperative Hemorrhage
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Renal Insufficiency
- Respiratory Insufficiency
- Respiratory Sounds
- Severe Acute Respiratory Syndrome
- Sleep Wake Disorders
- Stevens-Johnson Syndrome
- Syndrome
- Tetanus
Recent trials (50)
- NCT06254404Sponsor investigatorN/AMar 15, 2024
- NCT06254404Lead sponsorN/AMar 15, 2024
- NCT06062134Sponsor investigatorN/AMay 15, 2023
- NCT06062134Lead sponsorN/AMay 15, 2023
- NCT05440773Study chairN/AApr 30, 2023
- NCT05440773OfficialN/AApr 30, 2023
- NCT05790161CollaboratorN/AMar 31, 2023
- NCT05569772CollaboratorPhase 3Mar 31, 2023
- NCT05707234Reponsible party - principal investigatorPhase 4Feb 15, 2023
- NCT05707234Lead sponsorPhase 4Feb 15, 2023
- NCT05558449Reponsible party - principal investigatorPhase 4Dec 14, 2022
- NCT05558449Lead sponsorPhase 4Dec 14, 2022
- NCT05343507Sponsor investigatorPhase 2/Phase 3May 1, 2022
- NCT05343507Reponsible party - principal investigatorPhase 2/Phase 3May 1, 2022
- NCT05343507Lead sponsorPhase 2/Phase 3May 1, 2022
Details
- Founded
- Liege, BE Jun 1, 1817
- Last known activity
- Mar 15, 2024